Home LiteratureArticle Details
PMID: 4041727 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

The role of surgical local excision in the treatment of rectal cancer.

The British journal of surgery ·Vol. 72 ·No. 9 ·1985-09-00 ·Pages 694-7

Whiteway J, Nicholls RJ, Morson BC

Abstract

Selection of patients with ulcerating rectal cancer for treatment by local excision has been governed by a policy based on clinical and histological criteria; if these criteria are not fulfilled, major resection is recommended. This policy was re-examined in three groups of patients treated by local excision: Group 1 for cure (27 patients), Group 2 due to unfitness for major surgery (13 patients), Group 3 for local tumour control in the presence of metastatic disease (6 patients). When the policy was fulfilled, there was a cancer-specific death rate of 8.3 per cent in Group 1 (two patients with poorly differentiated tumours) and 0 per cent in Group 2. Unavoidable policy breaches occurred when patients refused major surgery or were too unfit: in the latter elderly group, this did not have the adverse effect expected. It is concluded that pre-operative clinical digital assessment and histological grading are a satisfactory means of identifying a small group of tumours appropriate for local treatment and that the results justify local excision where the policy is observed.

MeSH Terms
Adult Aged Female Humans Male Methods Middle Aged Prognosis Rectal Neoplasms/mortality,pathology,surgery Rectum/surgery Retrospective Studies
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Whiteway J
Nicholls R J
Morson B C
Article Info
Journal
The British journal of surgery
Abbr.
Br J Surg
ISSN
0007-1323
Published
1985-09-00
Pages
694-7
Language
English
Region
England
NLM ID
0372553
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com